SV Life Sciences Fund IV CF, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-03-25. The offering totals $421.4M, of which $421.4M was reported sold. Industry: Pooled Investment Fund.
| Name | Role | Location |
|---|---|---|
| Houman Ashrafian | Executive Officer | London, X0 |
| Michael Balmuth | Executive Officer | San Francisco, CA |
| Kate Bingham | Executive Officer | London, X0 |
| THOMAS FLYNN | Executive Officer | DENVER, CO |
| Eugene Hill | Executive Officer | Boston, MA |
| Paul LaViolette | Executive Officer | Seattle, WA |
| GREG MADDEN | Executive Officer | St. Paul, MN |
| Michael Ross | Executive Officer | South San Francisco, CA |
| N/A SV Life Sciences Fund IV CF (GP), LLC | Executive Officer | Boston, MA |